アルツハイマー病 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "アルツハイマー病" in Japanese language version.

refsWebsite

Global rank Japanese rank

59nih.gov

4^th place

24^th place

28doi.org

2^nd place

6^th place

13web.archive.org

1^st place

5nice.org.uk

3,258^th place

1,755^th place

2clinicaltrials.gov

5,225^th place

low place

1who.int

195^th place

376^th place

1worldcat.org

5^th place

19^th place

1ncgg.go.jp

low place

5,832^nd place

1fda.gov

447^th place

1,043^rd place

1psychologytoday.com

1,544^th place

1,642^nd place

1kin-en.info

low place

1wired.jp

7,091^st place

410^th place

1consumerreports.org

4,720^th place

low place

1nirs.go.jp

low place

1cbsnews.com

108^th place

622^nd place

1cell.com

2,814^th place

4,178^th place

1oup.com

485^th place

1,439^th place

1nytimes.com

7^th place

63^rd place

1mynavi.jp

393^rd place

30^th place

1eisai.co.jp

low place

4,562^nd place

1mhlw.go.jp

1,656^th place

110^th place

1pieronline.jp

low place

9,079^th place

1ls-corporation.co.jp

low place

cbsnews.com

Cold sore virus linked with Alzheimer's disease CBS news 2014.10.23

cell.com

Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. (2018). doi:10.1016/j.neuron.2018.05.023. [1]

clinicaltrials.gov

consumerreports.org

“Evaluating Prescription Drugs Used to Treat: Alzheimer's Disease Comparing Effectiveness, Safety, and Price” (PDF). Consumer Reports Drug Effectiveness Review Project (Consumer Reports). (May 2012) 1 May 2013閲覧。

doi.org

“Alzheimer disease”. Nat Rev Dis Primers 7 (1): 33. (May 2021). doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
“Alzheimer's disease”. BMJ 338: b158. (February 2009). doi:10.1136/bmj.b158. PMID 19196745.
“Alzheimer's disease”. The New England Journal of Medicine 362 (4): 329–344. (January 2010). doi:10.1056/NEJMra0909142. PMID 20107219.
“Survival in dementia and predictors of mortality: a review”. International Journal of Geriatric Psychiatry 28 (11): 1109–1124. (November 2013). doi:10.1002/gps.3946. PMID 23526458.
“Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer’s Disease”. J Alzheimers Dis. 86 (1): 271-281. (2022). doi:10.3233/JAD-215200.
“Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone”. Nature Medicine 30: 394-402. (2024). doi:10.1038/s41591-023-02729-2.
“Alzheimer Disease: An Update on Pathobiology and Treatment Strategies”. Cell 179 (2): 312–339. (October 2019). doi:10.1016/j.cell.2019.09.001. PMC 6778042. PMID 31564456.
“Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward”. Curr Alzheimer Res 14 (4): 426–440. (2017). doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
“Systematic review of information and support interventions for caregivers of people with dementia”. BMC Geriatrics 7: 18. (July 2007). doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
“Exercise programs for people with dementia”. The Cochrane Database of Systematic Reviews 132 (4): CD006489. (April 2015). doi:10.1002/14651858.CD006489.pub4. PMID 25874613.
“Comprehensive Review on Alzheimer's Disease: Causes and Treatment”. Molecules 25 (24): 5789. (December 2020). doi:10.3390/molecules25245789. PMC 7764106. PMID 33302541.
“Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD”. Archives of Medical Research 43 (8): 677–685. (November 2012). doi:10.1016/j.arcmed.2012.11.009. PMC 3532551. PMID 23178565.
“Alzheimer's pathogenic mechanisms and underlying sex difference”. Cell Mol Life Sci 78 (11): 4907–4920. (June 2021). doi:10.1007/s00018-021-03830-w. PMC 8720296. PMID 33844047.
“Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s”. Neurobiology of Aging 19 (3): 173–189. (1998). doi:10.1016/S0197-4580(98)00052-9. PMID 9661992.
大塚美恵子、「アルツハイマー病予防と摂取栄養素」『BRAIN and NERVE－神経研究の進歩』 68巻7号（2016年7月） p.809-817, doi:10.11477/mf.1416200513 （有償閲覧）
白澤卓二、「内科的アンチエイジング｝『順天堂医学』 2013年 59巻 4号 p.307-312, doi:10.14789/jmj.59.307
Grimm, M. O. W. (2011). “Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease”. Journal of Neurochemistry 116 (5): 916-925. doi:10.1111/j.1471-4159.2010.07070.x. PMID 21214572.
Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. (2018). doi:10.1016/j.neuron.2018.05.023. [1]
武洲、中西博、「古くて新しいアルツハイマー病の脳炎症仮説と感染症仮説－鍵を握るミクログリアの老化と慢性的脳炎症－」『日本薬理学雑』 2017年 150巻 3号 p.141-147, doi:10.1254/fpj.150.141
“Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors”. Science Advances. (2019). doi:10.1126/sciadv.aau3333.
熊谷亮、宇田川正子、飯塚美乃ほか、「【原著】アルツハイマー病の危険因子」『順天堂医学』 2004 年 50 巻 4 号 p. 392-398, doi:10.14789/pjmj.50.392
横野浩一、「糖尿病と認知症」『日本内科学会雑誌』 2010年 99巻 7号 p.1678-1684, doi:10.2169/naika.99.1678
Prevention recommendations not supported:
- Kawas CH (2006). “Medications and Diet: Protective Factors for AD?”. Alzheimer Disease and Associated Disorders 20 (3 Suppl 2): S89-96. doi:10.1097/00002093-200607001-00014. PMID 16917203.
- Birks JS, Harvey RJ (June 2018). “Donepezil for dementia due to Alzheimer's disease”. Cochrane Database Syst Rev 6: CD001190. doi:10.1002/14651858.CD001190.pub3. PMID 29923184.
- Birks JS, Chong LY, Grimley Evans J (September 2015). “Rivastigmine for Alzheimer's disease”. Cochrane Database Syst Rev 9: CD001191. doi:10.1002/14651858.CD001191.pub4. PMID 26393402.
- McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J (March 2019). “Memantine for dementia”. Cochrane Database Syst Rev 3: CD003154. doi:10.1002/14651858.CD003154.pub6. PMID 30891742.
- Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y (2018). “Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review”. Clin Interv Aging 13: 2061-2073. doi:10.2147/CIA.S184968. PMC 6201988. PMID 30425461.
- Iaccarino, et al. (2016). Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature.

eisai.co.jp

“「LEQEMBI®」（レカネマブ）、アルツハイマー病治療薬として、米国FDAよりフル承認を取得”. エーザイ株式会社・バイオジェン・インク (2023-7-7=). 2023年9月2日閲覧。

fda.gov

“Information for Healthcare Professionals: Conventional Antipsychotics”. US Food and Drug Administration (16 June 2008). 29 November 2014時点のオリジナルよりアーカイブ。29 November 2014閲覧。

kin-en.info

『受動喫煙は認知症のリスクを増大させる〜米国神経学会で発表〜』（プレスリリース）禁煙広報センター、2007年6月14日。オリジナルの2007年7月3日時点におけるアーカイブ。

ls-corporation.co.jp

エルゴチオネイン含有機能性表示食品

mhlw.go.jp

『かかりつけ医のためのBPSDに対応する向精神薬使用ガイドライン』（レポート）厚生労働省、2013年7月。

mynavi.jp

news.mynavi.jp

株式会社マイナビ. “中東の健康食にアルツハイマー病に有効な成分 - 東京工科大が発見マイナビニュース -”. 2013年10月10日閲覧。

ncgg.go.jp

“研究紹介コラム　認知症の新しい治療薬アデュカヌマブについて（１）｜国立長寿医療研究センター”. www.ncgg.go.jp. 2022年9月10日閲覧。

nice.org.uk

National Institute for Health and Clinical Excellence. “Low-dose antipsychotics in people with dementia”. National Institute for Health and Care Excellence (NICE). 5 December 2014時点のオリジナルよりアーカイブ。29 November 2014閲覧。
TA217: Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (Report). 英国国立医療技術評価機構. 2016年3月.
英国国立医療技術評価機構 2006, Chapt.1.7.3. 英国国立医療技術評価機構 (2006年11月). CG42 - Dementia: Supporting people with dementia and their carers in health and social care (Report).
英国国立医療技術評価機構 2006, Chapt.1.7.2. 英国国立医療技術評価機構 (2006年11月). CG42 - Dementia: Supporting people with dementia and their carers in health and social care (Report).

pathways.nice.org.uk

“Dementia diagnosis and assessment”. National Institute for Health and Care Excellence (NICE). 5 December 2014時点のオリジナルよりアーカイブ。30 November 2014閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

“Alzheimer disease”. Nat Rev Dis Primers 7 (1): 33. (May 2021). doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
“Alzheimer's disease”. BMJ 338: b158. (February 2009). doi:10.1136/bmj.b158. PMID 19196745.
“Alzheimer's disease”. The New England Journal of Medicine 362 (4): 329–344. (January 2010). doi:10.1056/NEJMra0909142. PMID 20107219.
“Survival in dementia and predictors of mortality: a review”. International Journal of Geriatric Psychiatry 28 (11): 1109–1124. (November 2013). doi:10.1002/gps.3946. PMID 23526458.
“Alzheimer Disease: An Update on Pathobiology and Treatment Strategies”. Cell 179 (2): 312–339. (October 2019). doi:10.1016/j.cell.2019.09.001. PMC 6778042. PMID 31564456.
“Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward”. Curr Alzheimer Res 14 (4): 426–440. (2017). doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
“Systematic review of information and support interventions for caregivers of people with dementia”. BMC Geriatrics 7: 18. (July 2007). doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
“Exercise programs for people with dementia”. The Cochrane Database of Systematic Reviews 132 (4): CD006489. (April 2015). doi:10.1002/14651858.CD006489.pub4. PMID 25874613.
“Comprehensive Review on Alzheimer's Disease: Causes and Treatment”. Molecules 25 (24): 5789. (December 2020). doi:10.3390/molecules25245789. PMC 7764106. PMID 33302541.
“Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD”. Archives of Medical Research 43 (8): 677–685. (November 2012). doi:10.1016/j.arcmed.2012.11.009. PMC 3532551. PMID 23178565.
“Alzheimer's pathogenic mechanisms and underlying sex difference”. Cell Mol Life Sci 78 (11): 4907–4920. (June 2021). doi:10.1007/s00018-021-03830-w. PMC 8720296. PMID 33844047.
“Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s”. Neurobiology of Aging 19 (3): 173–189. (1998). doi:10.1016/S0197-4580(98)00052-9. PMID 9661992.
Lancet Neurol. 2013 12 129-30 PMID 23246540
Nat Commun. 2014 5 3386. PMID 24577224
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):310-7. PMID 22203823
J Neurol Neurosurg Psychiatry. 2012 83 852-853. PMID 22338027
Neurology. 2004 Sep 28;63(6):975-82. PMID 15452286
Arch Neurol. 2002 Apr;59(4):588-93. PMID 11939893
Neurology. 1999 Jun 10;52(9):1839-44. PMID 10371532
J Geriatr Psychiatry Neurol. 1995 Jul;8(3):154-8. PMID 7576038
Arch Neurol. 1989 Jun;46(6):651-7. PMID 2730377
Ann Neurol. 1997 Mar;41(3):368-74. PMID 9066358
Front Aging Neurosci. 2023 Mar 21:15:1149036.　PMID 37025965
Alzheimers Dement. 2011 7 280-292. PMID 21514248
Nat Rev Neurol. 2015 11 457-470. PMID 26195256
J Am Geriatr Soc. 2005 Apr;53(4):695-9. PMID 15817019
Geriatr Gerontol Int. 2010 Jul;10(3):225-32. PMID 20141536
Parkinsonism Relat Disord. 2014 Nov;20(11):1145-8. PMID 25176439
Prevention recommendations not supported:
- Kawas CH (2006). “Medications and Diet: Protective Factors for AD?”. Alzheimer Disease and Associated Disorders 20 (3 Suppl 2): S89-96. doi:10.1097/00002093-200607001-00014. PMID 16917203.
- Birks JS, Harvey RJ (June 2018). “Donepezil for dementia due to Alzheimer's disease”. Cochrane Database Syst Rev 6: CD001190. doi:10.1002/14651858.CD001190.pub3. PMID 29923184.
- Birks JS, Chong LY, Grimley Evans J (September 2015). “Rivastigmine for Alzheimer's disease”. Cochrane Database Syst Rev 9: CD001191. doi:10.1002/14651858.CD001191.pub4. PMID 26393402.
- McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE, Maayan N, Ware J, Debarros J (March 2019). “Memantine for dementia”. Cochrane Database Syst Rev 3: CD003154. doi:10.1002/14651858.CD003154.pub6. PMID 30891742.
- Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y (2018). “Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review”. Clin Interv Aging 13: 2061-2073. doi:10.2147/CIA.S184968. PMC 6201988. PMID 30425461.
ncbi.nlm.nih.gov
- “Alzheimer disease”. Nat Rev Dis Primers 7 (1): 33. (May 2021). doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
- “Alzheimer Disease: An Update on Pathobiology and Treatment Strategies”. Cell 179 (2): 312–339. (October 2019). doi:10.1016/j.cell.2019.09.001. PMC 6778042. PMID 31564456.
- “Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward”. Curr Alzheimer Res 14 (4): 426–440. (2017). doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
- “Systematic review of information and support interventions for caregivers of people with dementia”. BMC Geriatrics 7: 18. (July 2007). doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
- “Comprehensive Review on Alzheimer's Disease: Causes and Treatment”. Molecules 25 (24): 5789. (December 2020). doi:10.3390/molecules25245789. PMC 7764106. PMID 33302541.
- “Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD”. Archives of Medical Research 43 (8): 677–685. (November 2012). doi:10.1016/j.arcmed.2012.11.009. PMC 3532551. PMID 23178565.
- “Alzheimer's pathogenic mechanisms and underlying sex difference”. Cell Mol Life Sci 78 (11): 4907–4920. (June 2021). doi:10.1007/s00018-021-03830-w. PMC 8720296. PMID 33844047.
- Acta Neuropathol. 1991;82(4):239-59.　PMID 1759558
- Acta Neuropathol. 2006 Oct;112(4):389-404.　PMID 16906426
- Acta Neuropathol. 1991;82(4):239-59.　PMID 1759558
- Neurology. 1991 Apr;41(4):479-86.　PMID 2011243
- Neurology. 2002 Jun 25;58(12):1791-800.　PMID 12084879
- Alzheimers Dement. 2012 Jan;8(1):1-13.　PMID 22265587
- Grimm, M. O. W. (2011). “Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease”. Journal of Neurochemistry 116 (5): 916-925. doi:10.1111/j.1471-4159.2010.07070.x. PMID 21214572.
- Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y (2018). “Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review”. Clin Interv Aging 13: 2061-2073. doi:10.2147/CIA.S184968. PMC 6201988. PMID 30425461.
pmc.ncbi.nlm.nih.gov
- “Alzheimer disease”. Nat Rev Dis Primers 7 (1): 33. (May 2021). doi:10.1038/s41572-021-00269-y. PMC 8574196. PMID 33986301.
- “Alzheimer Disease: An Update on Pathobiology and Treatment Strategies”. Cell 179 (2): 312–339. (October 2019). doi:10.1016/j.cell.2019.09.001. PMC 6778042. PMID 31564456.
- “Primary and secondary prevention trials in Alzheimer disease: looking back, moving forward”. Curr Alzheimer Res 14 (4): 426–440. (2017). doi:10.2174/1567205013666160930112125. PMC 5329133. PMID 27697063.
- “Systematic review of information and support interventions for caregivers of people with dementia”. BMC Geriatrics 7: 18. (July 2007). doi:10.1186/1471-2318-7-18. PMC 1951962. PMID 17662119.
- “Comprehensive Review on Alzheimer's Disease: Causes and Treatment”. Molecules 25 (24): 5789. (December 2020). doi:10.3390/molecules25245789. PMC 7764106. PMID 33302541.
- “Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD”. Archives of Medical Research 43 (8): 677–685. (November 2012). doi:10.1016/j.arcmed.2012.11.009. PMC 3532551. PMID 23178565.
- “Alzheimer's pathogenic mechanisms and underlying sex difference”. Cell Mol Life Sci 78 (11): 4907–4920. (June 2021). doi:10.1007/s00018-021-03830-w. PMC 8720296. PMID 33844047.
- Liang J, Li J, Jia R, Wang Y, Wu R, Zhang H, Hang L, Xu Y (2018). “Identification of the optimal cognitive drugs among Alzheimer's disease: a Bayesian meta-analytic review”. Clin Interv Aging 13: 2061-2073. doi:10.2147/CIA.S184968. PMC 6201988. PMID 30425461.
nia.nih.gov
- “Alzheimer's Disease Fact Sheet”. National Institute on Aging. 25 January 2021閲覧。
- “Study reveals how APOE4 gene may increase risk for dementia”. National Institute on Aging. 17 March 2021閲覧。
- “Alzheimer's Disease Fact Sheet” (英語). National Institute on Aging. 2022年3月23日閲覧。

nirs.go.jp

独立行政法人放射線医学総合研究所＞お知らせ・ご案内＞プレスリリース＞認知症で神経細胞死を引き起こす異常タンパク質の生体での可視化に世界で初めて成功

nytimes.com

Is Sugar Toxic？ Gary Taubes、The New York Times、2011年4月13日

oup.com

academic.oup.com

“Microbiota from Alzheimer’s patients induce deficits in cognition and hippocampal neurogenesis”. Oxford Academic. 2023年10月25日閲覧。

pieronline.jp

http://www.pieronline.jp/content/article/0386-3603/48040/685 健常者および軽度認知障害者に対するエルゴチオネイン含有食品の認知機能改善効果薬理と治療(2020)48（4）685-97

psychologytoday.com

Alzheimer's and High Blood Sugar Evolutionary Psychiatry、2011年9月20日

web.archive.org

“Dementia diagnosis and assessment”. National Institute for Health and Care Excellence (NICE). 5 December 2014時点のオリジナルよりアーカイブ。30 November 2014閲覧。
National Institute for Health and Clinical Excellence. “Low-dose antipsychotics in people with dementia”. National Institute for Health and Care Excellence (NICE). 5 December 2014時点のオリジナルよりアーカイブ。29 November 2014閲覧。
“Information for Healthcare Professionals: Conventional Antipsychotics”. US Food and Drug Administration (16 June 2008). 29 November 2014時点のオリジナルよりアーカイブ。29 November 2014閲覧。
「2025年に目指すべき社会の姿－『科学技術の俯瞰的予測調査』に基づく検討－」（2007年3月、科学技術政策研究所）^{[リンク切れ]}（アーカイブ）
“The scope and concerns of public health”. Oxford University Press: OUP.COM (2009年3月5日). 2010年12月3日閲覧。 ^{[リンク切れ]}（アーカイブ）
Preventing Alzheimer's Disease: What Do We Know?」米国の加齢研究所
『受動喫煙は認知症のリスクを増大させる〜米国神経学会で発表〜』（プレスリリース）禁煙広報センター、2007年6月14日。オリジナルの2007年7月3日時点におけるアーカイブ。
よくわかる「アルミニウムと健康」基礎知識^{[リンク切れ]}「アルミニウムと健康」連絡協議会（アーカイブ）
Insulin Resistance and Alzheimer's Disease: A Novel Therapeutic Target スライド2-5
“メマリー医薬品インタビューフォーム（第10版）” (PDF). www.info.pmda.go.jp. 2016年5月3日閲覧。
光の治療的応用―光による生体リズム調節 ^{[リンク切れ]}（アーカイブ）
アルツハイマー型痴呆患者の認知機能障害に対する高照度光療法の影響
Health Media Topics

who.int

“Dementia Fact sheet”. World Health Organization (September 2020). 2023年4月15日閲覧。

wired.jp

ニコチンの特性を生かした、神経系疾患向け合成薬 WIRED.jp

worldcat.org

Clinical neurology (Tenth ed.). [New York]: McGraw Hill. (2018). p. 111. ISBN 978-1-259-86173-4. OCLC 1012400314

アルツハイマー病 (Japanese Wikipedia)

cbsnews.com

cell.com

clinicaltrials.gov

consumerreports.org

doi.org

eisai.co.jp

fda.gov

kin-en.info

ls-corporation.co.jp

mhlw.go.jp

mynavi.jp

news.mynavi.jp

ncgg.go.jp

nice.org.uk

nice.org.uk

pathways.nice.org.uk

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

nia.nih.gov

nirs.go.jp

nytimes.com

oup.com

academic.oup.com

pieronline.jp

psychologytoday.com

web.archive.org

who.int

wired.jp

worldcat.org